Clinical Trials

RECRUITING
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer agents ...
Conditions:
Metastatic Castration-resistant Prostate Cancer
Locations:
📍 Salt Lake City, Utah, United States
RECRUITING
Caris Biorepository Research Protocol
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for resear...
Conditions:
Cancer
Locations:
📍 Albany, Georgia, United States
📍 West Des Moines, Iowa, United States
📍 New Bern, North Carolina, United States
📍 Nashville, Tennessee, United States
3 more locations available...
RECRUITING
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
This phase I/II trial studies the side effect and best dose of steroid therapy (prednisone or methylprednisolone) in improving symptoms of late radiat...
Conditions:
Cranial Nerve Disorder Head and Neck Carcinoma Oropharyngeal Carcinoma
Locations:
📍 Houston, Texas, United States
RECRUITING
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Single-arm, open label study to determine the 18 week progression-free survival rate of the combination of BXCL701 and pembrolizumab in patients with ...
Conditions:
Metastatic Pancreatic Ductal Adenocarcinoma
Locations:
📍 Washington, District of Columbia, United States
RECRUITING
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
This phase I/II trial studies the best dose, possible benefits and/or side effects of oral azacitidine in treating patients with T-cell large granular...
Conditions:
T-Cell Large Granular Lymphocyte Leukemia
Locations:
📍 Columbus, Ohio, United States
RECRUITING
Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer th...
Conditions:
Extensive Stage Lung Small Cell Carcinoma Metastatic Lung Small Cell Carcinoma Recurrent Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8
2 more conditions available...
Locations:
📍 Chicago, Illinois, United States
📍 Indianapolis, Indiana, United States
📍 Iowa City, Iowa, United States
📍 Columbus, Ohio, United States
1 more location available...
RECRUITING
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T...
Conditions:
Relapsed or Refractory T Cell Lymphoma
Locations:
📍 Birmingham, Alabama, United States
📍 Duarte, California, United States
📍 Orange, California, United States
📍 Boston, Massachusetts, United States
8 more locations available...
RECRUITING
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
The purpose of this research study is to find out how safe and effective is treating patients with locally advanced rectal cancer (LARC) with chemothe...
Conditions:
Locally Advanced Rectal Cancer
Locations:
📍 Miami, Florida, United States
RECRUITING
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
This phase II trial investigates how well duloxetine and neurofeedback training work in treating patients with chemotherapy induced peripheral neuropa...
Conditions:
Chemotherapy-Induced Peripheral Neuropathy Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm
Locations:
📍 Houston, Texas, United States
📍 Houston, Texas, United States
RECRUITING
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection
This is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and prel...
Conditions:
Advanced Solid Tumours Endometrial Cancer Cervical Cancer Ovarian Cancer
6 more conditions available...
Locations:
📍 Duarte, California, United States
📍 Boston, Massachusetts, United States
📍 Minneapolis, Minnesota, United States
📍 Buffalo, New York, United States
9 more locations available...
RECRUITING
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma...
Conditions:
Endometrial Cancer
Locations:
📍 Birmingham, Alabama, United States
📍 Phoenix, Arizona, United States
📍 Little Rock, Arkansas, United States
📍 Duarte, California, United States
159 more locations available...
RECRUITING
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Subjects on this study have a type of lymph gland cancer called Non-Hodgkin Lymphoma, acute lymphocytic leukemia, or chronic Lymphocytic Leukemia (the...
Conditions:
Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Acute Lymphocytic Leukemia
Locations:
📍 Houston, Texas, United States
📍 Houston, Texas, United States
NOT_YET_RECRUITING
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
To compare the results of the SOCS-OTS to another standardized screening measure that is currently being used by rehabilitation services at MD Anderso...
Conditions:
Cancer Occupational Therapy
Locations:
📍 Houston, Texas, United States
RECRUITING
Stool Sample Collection Study
The primary objective of this study is to obtain de-identified stool specimens from participants with colonoscopic biopsy-based histopathologic diagno...
Conditions:
Colorectal Cancer
Locations:
📍 Anaheim, California, United States
📍 Ocala, Florida, United States
📍 Cordova, Tennessee, United States
RECRUITING
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide. The purpose of this...
Conditions:
Metastatic Castration-Resistant Prostate Cancer
Locations:
📍 Duarte, California, United States
📍 Grand Rapids, Michigan, United States
📍 Huntersville, North Carolina, United States
📍 Providence, Rhode Island, United States
5 more locations available...

Total Trials: 196 - 210 of 6772